FAST NEWS: Hillhouse invests $22 million in Legend Biotech
The latest: Genscript Biotech Corp. (1548.HK) announced on Sunday that its New York-listed subsidiary Legend Biotech Corp. (LEGN.US) has sold 692,782 shares through a private placement to LGN Holdings Ltd.,…
Recent Articles
RELATED ARTICLES
-
GenScript losses shrink on strong growth for cancer cell therapy
1548.HK -
Will Genscript cash out of Legend Biotech in the face of fat profit temptation?
1548.HK LEGN.US
-
Legend Holdings shows diversification isn’t always a winning formula
3396.HK
-
FAST NEWS: Genscript’s controlling shareholder sells shares to Hillhouse Capital
1548.HK
-
NEWS BRIEF: Legend Biotech’s revenue doubles on big gains for CAR-T treatment
LEGN.US
- CHINA BULLETIN: Manufacturing Déjà Vu
- CHINA BULLETIN: Services, Trade Send Positive Signals
